Liposomes and micellar dispersions for delivery of benzoheterocyclic derivatives of distamycin A

Drug Delivery

Volumn 14, Issue 1, 2007, Pages 1-8

  Cortesi, Rita ^a,d   Esposito, E ^a   Cuccu, I ^a   Romagnoli, R ^a   Menegatti, E ^a   Zaid, A N ^a,b   Nastruzzi, C ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Dipartimento di Scienze Farmaceutiche   (Italy)

Author keywords

Antiproliferative Activity; Distamycins; Liposome; Micelle; Specialized Delivery Systems

Indexed keywords

DISTAMYCIN A DERIVATIVE; LIPOSOME; POLYCARBONATE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DISPERSION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; DRUG SYNTHESIS; ENCAPSULATION; EVAPORATION; FILTER; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MICELLE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICOLOGY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DISTAMYCINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FREEZE FRACTURING; HETEROCYCLIC COMPOUNDS; HUMANS; K562 CELLS; LEUKEMIA L1210; LIPOSOMES; MEMBRANES, ARTIFICIAL; MICE; MICELLES; MICROSCOPY, ELECTRON; PARTICLE SIZE; SOLUBILITY;

EID: 33751093778     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540600640211     Document Type: Article

References (20)

1. Agen, C., Sironi, A. M., Danesi, R., et al. 1992. Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart. Toxicology 75:209-221.
2. Attwood, D. 1994. Microemulsions. In Colloidal Drug Delivery Systems, ed. Kreuter, J., 31-71. New York: Marcel Dekker.
3. Baraldi, P. G., Romagnoli, R., Beria, I., et al. 2000. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin Amer. J. Med. Chem. 43:2675-2684.
4. Beran, M., Jeha, S., O'Brien, S., 1998. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study. Clin. Cancer Res. 4:53-59.
5. Bouffard, P., Mamish, D., Baginski, I., et al. 1993. Infection of a leukemic cell line (K562) by hepatitis B virus induces cell growth inhibition. J. Hepatol. 17:384-389.
6. Cortesi, R., Esposito, E., Maietti, A. et al., 1997. Formulation study for the antitumor drug camptothecin: liposome, micellar solutions and a microemulsion. Int. J. Pharm. 159:95-103.
7. Cozzi, P., and Mongelli, N. 1998. Cytotoxics derived from distamycin A and congeners. Curr. Pharm. Des. 4:181-201.
8. Cozzi, P. 2000. Recent outcome in the field of distamycin-derived minor groove binders. Farmaco 55:168-173.
9. Cozzi, P. 2001. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers. Farmaco 56:57-65.
10. De Oliveira, A. G., and Chaimovich, H. 1993. Effect of detergents and other amphiphiles on the stability of pharmaceutical drugs. J. Pharm. Pharmacol. 45:850-861.
11. Garcia Sagrado, F., Guzman, M., Molpeceres, J., and Abeturas, M. R. 1994. Pluronic copolymers-characteristics, properties and pharmaceutical applications: part I. Pharm. Technol. Eur. 5:46-56.
12. Jordheim, L. P., Cros, E., Gouy, M. H., et al. 2004. Characterization of a gemcitabine-resistant murine leukemic cell line. Clin. Cancer Res. 10:5614-5621.
13. Kakemi, K., Sezaki, H., Konishi, R., et al. 1993. Effect of bile salts on the gastrointestinal absorption of drugs. I. Chem. Pharm. Bull. 18:275-280.
14. Lech-Maranda, E., Korycka, A., and Robak, T. 2000. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro. Haematologica 85:588-594.
15. Lian, T., and Ho, R. J. Y. 2001. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90:667-680.
16. Lozzio, C. B., and Lozzio, B. B. 1975. Human chronic myelogeneous leukemia cell line with positive Philadelphia chromosome. Blood 45:321-334.
17. Marchini, S., Broggini, M., Sessa, C., and D'Incalci, M. 2001. Development of distamycin-related DNA binding anticancer drugs. Expert. Opin. Investig. Drugs 10:1703-1714.
18. Punt, C. J., Humblet, Y., Roca, E., et al. 1996. Tallimustine in advanced previously untreated colorectal cancer, a phase II study. Br. J. Cancer 73:803-804.
19. Tagliabue, G., Filippini, C. Ubezio, P., and D'Incalci, M. 1997. Combination of the new minor groove alkylator tallimustine and melphalan. Eur. J. Cancer 33:284-287.
20. Weiss, G. R., Poggesi, I., Rocchetti, M., et al. 1997. A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer. Clin. Cancer Res. 3:2377-2384.